C65H57BBrCl6N13O9S5 — CID 160668097
N-[6-(5-amino-6-chloro-3-pyridinyl)-1,3-benzothiazol-2-yl]acetamide;5-bromo-2-chloropyridin-3-amine;4-chlorobenzenesulfonyl chloride;N-[6-[6-chloro-5-[(4-chlorophenyl)sulfonylamino]-3-pyridinyl]-1,3-benzothiazol-2-yl]acetamide;pyridine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide (PubChem CID 160668097) has the molecular formula C65H57BBrCl6N13O9S5 and a molecular weight of 1628.02 g/mol. Its IUPAC name is N-[6-(5-amino-6-chloro-3-pyridinyl)-1,3-benzothiazol-2-yl]acetamide;5-bromo-2-chloropyridin-3-amine;4-chlorobenzenesulfonyl chloride;N-[6-[6-chloro-5-[(4-chlorophenyl)sulfonylamino]-3-pyridinyl]-1,3-benzothiazol-2-yl]acetamide;pyridine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide.
| Compound Name | N-[6-(5-amino-6-chloro-3-pyridinyl)-1,3-benzothiazol-2-yl]acetamide;5-bromo-2-chloropyridin-3-amine;4-chlorobenzenesulfonyl chloride;N-[6-[6-chloro-5-[(4-chlorophenyl)sulfonylamino]-3-pyridinyl]-1,3-benzothiazol-2-yl]acetamide;pyridine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide |
|---|---|
| PubChem CID | 160668097 |
| Molecular Formula | C65H57BBrCl6N13O9S5 |
| Molecular Weight | 1628.02 g/mol |
| Exact Mass | 1623.04 |
| IUPAC Name | N-[6-(5-amino-6-chloro-3-pyridinyl)-1,3-benzothiazol-2-yl]acetamide;5-bromo-2-chloropyridin-3-amine;4-chlorobenzenesulfonyl chloride;N-[6-[6-chloro-5-[(4-chlorophenyl)sulfonylamino]-3-pyridinyl]-1,3-benzothiazol-2-yl]acetamide;pyridine;N-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-yl]acetamide |
| SMILES | CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(N)c3)cc2s1.CC(=O)Nc1nc2ccc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(Cl)cc4)c3)cc2s1.CC(=O)Nc1nc2ccc(B3OC(C)(C)C(C)(C)O3)cc2s1.Nc1cc(Br)cnc1Cl.O=S(=O)(Cl)c1ccc(Cl)cc1.c1ccncc1 |
| InChI | InChI=1S/C20H14Cl2N4O3S2.C15H19BN2O3S.C14H11ClN4OS.C6H4Cl2O2S.C5H4BrClN2.C5H5N/c1-11(27)24-20-25-16-7-2-12(9-18(16)30-20)13-8-17(19(22)23-10-13)26-31(28,29)15-5-3-14(21)4-6-15;1-9(19)17-13-18-11-7-6-10(8-12(11)22-13)16-20-14(2,3)15(4,5)21-16;1-7(20)18-14-19-11-3-2-8(5-12(11)21-14)9-4-10(16)13(15)17-6-9;7-5-1-3-6(4-2-5)11(8,9)10;6-3-1-4(8)5(7)9-2-3;1-2-4-6-5-3-1/h2-10,26H,1H3,(H,24,25,27);6-8H,1-5H3,(H,17,18,19);2-6H,16H2,1H3,(H,18,19,20);1-4H;1-2H,8H2;1-5H |
| InChIKey | RMOPFCBNKNWWSZ-UHFFFAOYSA-N |
| XLogP | 16.96 |
| TPSA | 328.34 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 100 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1628.02 |
| LogP ≤ 5 | 16.96 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 21 |
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|